Article info

Download PDFPDF

Is ex vivo adenovirus mediated gene transfer a therapeutic option for the treatment of corneal diseases?
Free
  1. Correspondence to: Thomas Ritter PhD, Institute of Medical Immunology, Charité–University Medicine Berlin, Campus Mitte, Monbijoustrasse 2a, 10117 Berlin, Germany; thomas.rittercharite.de
View Full Text

Citation

Ritter T, Gong N, Pleyer U
Is ex vivo adenovirus mediated gene transfer a therapeutic option for the treatment of corneal diseases?

Publication history

  • First published May 27, 2005.
Online issue publication 
May 27, 2005

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.